• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    SciSparc Ltd. - Ordinary Shares (NQ: SPRC )

    0.4726 -0.0224 (-4.53%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 348,024
    Open 0.5056
    Bid (Size) 0.4651 (5)
    Ask (Size) 0.4699 (5)
    Prev. Close 0.4950
    Today's Range 0.4621 - 0.5056
    52wk Range 0.4901 - 15.86
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer
    From SciSparc Ltd
    Via GlobeNewswire
    SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million
    From SciSparc Ltd
    Via GlobeNewswire

    Performance

    YTD
    -90.72%
    -90.72%
    1 Month
    -47.38%
    -47.38%
    3 Month
    -62.49%
    -62.49%
    6 Month
    -92.29%
    -92.29%
    1 Year
    -96.50%
    -96.50%

    More News

    Read More
    Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
    From SciSparc Ltd
    Via GlobeNewswire
    Mizuho Just Issued a Warning on Palantir (PLTR) Stock
    Via InvestorPlace
    Why Is SciSparc (SPRC) Stock Up 25% Today?
    Via InvestorPlace
    Topics Intellectual Property
    Exposures Intellectual Property
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss
    From SciSparc Ltd
    Via GlobeNewswire
    Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company
    From SciSparc Ltd
    Via GlobeNewswire
    SciSparc Secures Strategic Advantage with Grant of European Patent
    From SciSparc Ltd
    Via GlobeNewswire
    Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification
    Via Benzinga
    SciSparc to Acquire AutoMax
    From SciSparc Ltd
    Via GlobeNewswire
    Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
    From SciSparc Ltd
    Via GlobeNewswire
    SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
    From SciSparc Ltd
    Via GlobeNewswire
    SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
    From SciSparc Ltd
    Via GlobeNewswire
    SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
    From SciSparc Ltd
    Via GlobeNewswire
    Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
    Via Benzinga
    SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
    From SciSparc Ltd
    Via GlobeNewswire
    Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder
    From SciSparc Ltd
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.